Drug stocks slide; Biogen falls on PML update

Drug stocks slide into the red as shares of Biogen Idec fall on news that another case of brain disease PML had been discovered in a user of its multiple-sclerosis drug Tysabri.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.